298 related articles for article (PubMed ID: 8576937)
1. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
Sanbe A; Tanonaka K; Kobayasi R; Takeo S
J Mol Cell Cardiol; 1995 Oct; 27(10):2209-22. PubMed ID: 8576937
[TBL] [Abstract][Full Text] [Related]
2. Effects of trandolapril on cardiac angiotensin I converting enzyme activity in rats with chronic heart failure following myocardial infarction.
Sanbe A; Tsukada J; Takeo S
Jpn Heart J; 1995 Jul; 36(4):451-63. PubMed ID: 7474361
[TBL] [Abstract][Full Text] [Related]
3. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril.
Toga W; Tanonaka K; Takeo S
Biol Pharm Bull; 2007 Jan; 30(1):105-10. PubMed ID: 17202668
[TBL] [Abstract][Full Text] [Related]
4. Effects of ACE inhibition and beta-receptor blockade on energy metabolism in rats postmyocardial infarction.
Hügel S; Horn M; de Groot M; Remkes H; Dienesch C; Hu K; Ertl G; Neubauer S
Am J Physiol; 1999 Dec; 277(6):H2167-75. PubMed ID: 10600834
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
Sanbe A; Takeo S
Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
[TBL] [Abstract][Full Text] [Related]
6. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
Sanbe A; Tanonaka K; Niwano Y; Takeo S
J Pharmacol Exp Ther; 1994 Apr; 269(1):51-6. PubMed ID: 8169851
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Takeda H; Haneda T; Kikuchi K
Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
[TBL] [Abstract][Full Text] [Related]
10. Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril.
Horn M; Neubauer S; Frantz S; Hugel S; Hu K; Gaudron P; Schnackerz K; Ertl G
J Cardiovasc Pharmacol; 1996 Feb; 27(2):201-10. PubMed ID: 8720418
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of trandolapril on experimentally induced congestive heart failure in rats.
Fornes P; Richer C; Pussard E; Heudes D; Domergue V; Giudicelli JF
Am J Cardiol; 1992 Oct; 70(12):43D-51D. PubMed ID: 1414925
[TBL] [Abstract][Full Text] [Related]
12. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
Nakazawa M; Ishihara T; Takahashi Y; Okuhira M; Imai S
J Cardiovasc Pharmacol; 1993 Oct; 22(4):585-93. PubMed ID: 7505361
[TBL] [Abstract][Full Text] [Related]
13. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
[TBL] [Abstract][Full Text] [Related]
14. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Optimizing ischemia/reperfusion in the failing rat heart--improved myocardial protection with acute ACE inhibition.
Podesser BK; Schirnhofer J; Bernecker OY; Kröner A; Franz M; Semsroth S; Fellner B; Neumüller J; Hallström S; Wolner E
Circulation; 2002 Sep; 106(12 Suppl 1):I277-83. PubMed ID: 12354746
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarction.
Tanonaka K; Toga W; Yoshida H; Furuhama K; Takeo S
Br J Pharmacol; 2001 Nov; 134(5):969-76. PubMed ID: 11682444
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.
Richer C; Mulder P; Fornes P; Domergue V; Heudes D; Giudicelli JF
J Cardiovasc Pharmacol; 1992 Jul; 20(1):147-56. PubMed ID: 1383624
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.
Mitręga KA; Spałek AM; Nożyński J; Porc M; Stankiewicz M; Krzemiński TF
PLoS One; 2017; 12(6):e0179633. PubMed ID: 28636634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
